A phase I and pharmacokinetic (PK) study of the novel mushroom-derived cytotoxin, MGI114, in patients with advanced cancer

被引：0
|
作者：
Eckhardt, SG
Baker, SD
Moczygemba, J
MacDonald, JR
Smith, S
Von Hoff, DD
Rowinsky, EK
机构：
[1] Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[2] MGI Pharma, Minnetonka, MN USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
471
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [31] A phase I pharmacokinetic study of declopramide in combination with cisplatin in patients with advanced cancer.
    Remick, S
    Dowlati, A
    Robertson, K
    Buchter, C
    Ingalls, S
    Hoppel, C
    Spiro, T
    Makkar, V
    Overmoyer, B
    Gerson, S
    ANNALS OF ONCOLOGY, 2000, 11 : 138 - 138
  • [32] A Phase I and pharmacokinetic(PK) study of trabectedin (Yondelis®) and cisplatin (P) in patients with advanced solid tumors including platinum resistant ovarian cancer
    Sessa, Cristiana
    Colombo, Nicoletta
    Cresta, Sara
    De Braud, Filippo
    De Pas, Martino
    D'lncalci, Maurizio
    Jimeno, Jose
    Ferrario, Cristiano
    Raspagliesi, Francesco
    Gianni, Luca
    ANNALS OF ONCOLOGY, 2004, 15 : 128 - 128
  • [33] Phase I and pharmacokinetic (PK) study of IHL-305 (pegylated liposomal irinotecan) in patients with advanced solid tumors
    Jones, S. F.
    Zamboni, W. C.
    Burris, H. A., III
    Chan, E.
    Infante, J. R.
    Keedy, V.
    Bendell, J. C.
    Lee, W.
    Ikeda, S.
    Rothenberg, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Phase I pharmacokinetic (PK) and safety study of intravenous (IV) Cl-1033 in patients with advanced solid tumors
    Simon, GR
    Olson, S
    Garrett, CR
    Eiseman, I
    Langevin, M
    Mahany, JJ
    Sullivan, DM
    Schlicht, MG
    Lush, R
    Lanehan, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 209S - 209S
  • [35] Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
    Hamberg, P.
    Steeghs, N.
    Loos, W. J.
    van der Biessen, D. J.
    den Hollander, M. A.
    Tascilar, M.
    Verweij, J.
    Gelderblom, H.
    Sleijfer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors
    Rowinsky, EK
    Pacey, S
    Patnaik, A
    O'Donnell, A
    Mita, MM
    Atadja, P
    Peng, B
    Dugan, M
    Scott, JW
    De Bono, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 200S - 200S
  • [37] A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer
    Bhargava, P
    Marshall, JL
    Rizvi, N
    Dahut, W
    Yoe, J
    Figuera, M
    Phipps, K
    Ong, VS
    Kato, A
    Hawkins, MJ
    CLINICAL CANCER RESEARCH, 1999, 5 (08) : 1989 - 1995
  • [38] Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer
    Clarke, K
    Basser, RL
    Maher, D
    Morgan, DJ
    Cebon, J
    Fox, RM
    Hill, JS
    Alt, C
    Bartlet, J
    Geldard, H
    Kaye, AH
    Green, MD
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2181 - 2187
  • [39] Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
    Voon, Pei Jye
    Chen, Eric X.
    Chen, Helen X.
    Lockhart, Albert C.
    Sahebjam, Solmaz
    Kelly, Karen
    Vaishampayan, Ulka N.
    Subbiah, Vivek
    Razak, Albiruni R.
    Renouf, Daniel J.
    Hotte, Sebastien J.
    Singh, Arti
    Bedard, Philippe L.
    Hansen, Aaron R.
    Ivy, S. Percy
    Wang, Lisa
    Stayner, Lee-Anne
    Siu, Lillian L.
    Spreafico, Anna
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [40] Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancer
    Patnaik, A
    Rowinsky, EK
    Tammara, BK
    Hidalgo, M
    Drengler, RL
    Garner, AM
    Siu, LL
    Hammond, LA
    Felton, SA
    Mallikaarjun, S
    Von Hoff, DD
    Eckhardt, SG
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3974 - 3985
12345